Basic Information | Post buying leads | Suppliers |
Name |
Lithium antimony thiomalate |
EINECS | N/A |
CAS No. | 305-97-5 | Density | g/cm3 |
PSA | 240.78000 | LogP | -9.62460 |
Solubility | N/A | Melting Point |
N/A |
Formula | C4H6 O4 S . 2 Li . 1/3 Sb | Boiling Point | 256.3°Cat760mmHg |
Molecular Weight | 604.78 | Flash Point | 108.8°C |
Transport Information | N/A | Appearance | N/A |
Safety | Poison by intraperitoneal and intravenous routes. Human systemic effects by ingestion and intravenous routes: hallucinations, distorted perceptions, nausea or vomiting, skin dermatitis, and fever. An anthelmintic agent. When heated to decomposition it emits very toxic fumes of SOx, Sb, and Li2O. See also ANTIMONY COMPOUNDS and LITHIUM COMPOUNDS. | Risk Codes | N/A |
Molecular Structure | Hazard Symbols | N/A | |
Synonyms |
Butanedioicacid, 2,2',2''-[stibylidynetris(thio)]tris-, hexalithium salt; Butanedioicacid, mercapto-, antimony(3+) lithium salt (3:1:6) (9CI); Succinic acid,mercapto-, antimonate(III), hexalithium salt (7CI); Succinic acid, mercapto-,triester with thioantimonic acid (H3SbS3), hexalithium salt (8CI);Thioantimonic acid (H3SbS3), triester with mercaptosuccinic acid, hexalithiumsalt (8CI); Anthiolimin; Anthiolimine; Anthiomaline; LAT; Lithiumantimoniothiomalate; Lithium antimony thiomalate |
Molecular Structure of Lithium antimony thiomalate (CAS NO. 305-97-5):
IUPAC Name: Hexalithium 2-bis[(1,4-dioxido-1,4-dioxobutan-2-yl)sulfanyl]stibanylsulfanylbutanedioate
Molecular Formula: C12H9Li6O12S3Sb
Molecular Weight: 604.793660 g/mol
H-Bond Donor: 0
H-Bond Acceptor: 12
Canonical SMILES: [Li+].[Li+].[Li+].[Li+].[Li+].[Li+].C(C(C(=O)[O-])S[Sb](SC(CC(=O)[O-])C(=O)[O-])SC(CC(=O)[O-])C(=O)[O-])C(=O)[O-]
InChI: InChI=1S/3C4H6O4S.6Li.Sb/c3*5-3(6)1-2(9)4(7)8;;;;;;;/h3*2,9H,1H2,(H,5,6)(H,7,8);;;;;;;/q;;;6*+1;+3/p-9
InChIKey: YECBTZNXNRHKJD-UHFFFAOYSA-E
Flash Point: 108.8 °C
Enthalpy of Vaporization: 54.37 kJ/mol
Boiling Point: 256.3 °C at 760 mmHg
Vapour Pressure of Lithium antimony thiomalate (CAS NO. 305-97-5): 0.00475 mmHg at 25 °C
1. | orl-hmn TDLo:11 mg/kg:GIT,MET | JAMAAP JAMA, Journal of the American Medical Association. 125 (1944),952. | ||
2. | ivn-man TDLo:262 mg/kg/5W-I:CNS,SKN | METRA2 Medecine Tropicale (Marseille). 19 (1959),103. | ||
3. | ipr-mus LD50:82 mg/kg | AJTMAQ American Journal of Tropical Medicine. 25 (1945),263. | ||
4. | ivn-mus LD50:181 mg/kg | JPETAB Journal of Pharmacology and Experimental Therapeutics. 81 (1944),224. |
Antimony and its compounds are on the Community Right-To-Know List.
Poison by intraperitoneal and intravenous routes. Human systemic effects by ingestion and intravenous routes: hallucinations, distorted perceptions, nausea or vomiting, skin dermatitis, and fever. An anthelmintic agent. When heated to decomposition it emits very toxic fumes of SOx, Sb, and Li2O. See also ANTIMONY COMPOUNDS and LITHIUM COMPOUNDS.
OSHA PEL: TWA 0.5 mg(Sb)/m3
ACGIH TLV: TWA 0.5 mg(Sb)/m3
NIOSH REL: (Antimony) TWA 0.5 mg(Sb)/m3
Lithium antimony thiomalate with cas registry number of 305-97-5 is also known as 2,2',2"-(Stibilidynetris(thio)tris-butanedioic acid) hexalithium salt ; AI3-15246 ; Anthiolimine ; Anthioliminum ; Anthioliminum [INN-Latin] ; Anthiomaline ; Antimony lithium thiomalate ; Antiolimina ; Antiolimina [INN-Spanish] ; Anthiolimine [INN] ; Butanedioic acid, 2,2',2''-(stibylidynetris(thio))tris-, hexalithium salt ; Hexalithium 5,5',5''-stibeintriyltris(2-thiosuccinat) ; Lithium antimoniothiomalate ; Mercaptosuccinic acid S-antimony derivative lithium salt ; Mercaptosuccinic acid antimonate (III) hexalithium salt ; Mercaptosuccinic acid triester with thioantimonic acid (H3SbS3), hexalithium salt ; RP 110 L ; Succinic acid, mercapto-, thioantimonate(III), dilithium salt ; Stibine, tris((1,2-dicarboxyethyl)thio)-, hexalithium salt ; Tris((1,2-dicarboxyethyl)thio)stibine hexalithium salt ; UNII-TX973XBY8N .